Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 10
Submit an article Journal homepage
272
Views
3
CrossRef citations to date
0
Altmetric
Letter

Successful treatment of post-transplant Epstein–Barr virus-related meningoencephalitis by intravenous rituximab monotherapy

Roberto CrocchioloInstitut Paoli-Calmettes, Marseille, France,Correspondence[email protected]
,
Joseph CiccoliniLaboratoire de Pharmacocinetique, Hopital La Timone, Marseille, France,
,
Jean El-CheikhInstitut Paoli-Calmettes, Marseille, France,
,
Sabine FürstInstitut Paoli-Calmettes, Marseille, France,
,
Luca CastagnaInstitut Paoli-Calmettes, Marseille, France,
,
Angela GranataInstitut Paoli-Calmettes, Marseille, France,
,
Claire OudinInstitut Paoli-Calmettes, Marseille, France,
,
Samia HarbiInstitut Paoli-Calmettes, Marseille, France,
,
Raynier DevillierInstitut Paoli-Calmettes, Marseille, France,
,
Stevan LegallCentre Hospitalier Intercommunal des Alpes du sud, Gap, France and
,
David TernantLaboratoire de Pharmacologie-Toxicologie, Hôpital Bretonneau, Tours, France
,
Gilles PaintaudLaboratoire de Pharmacologie-Toxicologie, Hôpital Bretonneau, Tours, France
,
Bruno LacarelleLaboratoire de Pharmacocinetique, Hopital La Timone, Marseille, France,
&
Didier BlaiseInstitut Paoli-Calmettes, Marseille, France,
 show all
Pages 2063-2065 | Received 06 Jan 2012, Accepted 18 Feb 2012, Published online: 19 Apr 2012

References

  • Heslop HE, Congfen L, Krance RA. Epstein-Barr infection after bone marrow transplantation. Blood 1994;83:1706–1710.
  • Kuehnle I, Huls MH, Liu Z, . CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood 2000;95:1502–1505.
  • Milpied N, Vasseur B, Parquet N, . Humanized anti-CD20 monoclonal antibody (rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Ann Oncol 2000;11(Suppl. 1):S113–S116.
  • Polilli E, Sozio F, Mazzotta E, . Rapidly progressive and fatal EBV-related encephalitis in a patient with advanced HIV-1 infection at presentation: a case report and review of literature. New Microbiol 2010;33:275–280.
  • Kittan NA, Beier F, Kurk K, . Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges. Transpl Infect Dis 2011;13:524–530.
  • van de Glind G, de Graaf S, Klein C, . Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system. Pediatr Blood Cancer 2008;50: 886–888.
  • Bonney DK, Htwe EE, Turner A, . Sustained response to intrathecal rituximab in EBV associated post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant. Pediatr Blood Cancer 2012;58:459–461.
  • Shah GD, Yahalom J, Correa DD, . Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 2007;25: 4730–4735.
  • Batchelor TT, Lesser GJ, Grossman SA. Rituximab monotherapy for relapsed or refractory primary central nervous system lymphoma. J Clin Oncol 2008;26:(Suppl.): Abstract 2043.
  • Ferreri AJ. How I treat primary CNS lymphoma. Blood 2011;118:510–522.
  • Harjunpaa A, Wiklund T, Collan J, . Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphoma. Leuk Lymphoma 2001;42:731–738.
  • Hänel M, Fiedler F, Thorns C. Anti-CD20 monoclonal antibody (rituximab) and cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement. Onkologie 2001;24:491–494.
  • Nozzoli C, Bartolozzi B, Guidi S, . Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 2006;47:167–169.
  • Kordelas L, Trenschel R, Koldehoff M, . Successful treatment of EBV PTLD with CNS lymphomas with the monoclonal anti-CD20 antibody rituximab. Onkologie 2008;31:691–693.
  • Pakakasama S, Eames GM, Morriss MC, . Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes. Transplantation 2004;78:755–757.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.